Vulvar Cancer

Research

Mayo Clinic is a member of the Gynecologic Oncology Group (GOG), a national organization whose members conduct research to find the best treatments for gynecologic cancers. In addition, the National Cancer Institute (NCI) has designated Mayo Clinic Cancer Center as a comprehensive cancer center. NCI has determined that cancer researchers and clinicians at Mayo meet stringent patient care standards while researching innovative potential therapies for cancer.

The surgical removal of lymph nodes to test for the spread of cancer is often a normal part of treatment for vulvar tumors. This procedure can cause unpleasant side effects such as swollen legs. Mayo Clinic's gynecological oncologists are participating in a national Gynecologic Oncology Group (GOG) study to test whether less radical measures — related to lymph node removal — can be used to detect the spread of the disease.

Women's Cancer Program

The Women's Cancer Program at Mayo Clinic conducts cutting-edge, innovative research to improve treatment management options for women with breast and gynecologic cancers. This multidisciplinary program brings together researchers and clinicians to further the current understanding of women's cancers, provide compassionate care, and educate patients and their families about women's cancers. Researchers in gynecologic surgery, medical and radiation oncology, medical genetics, pathology and other specialties work together to give women with cancer the widest possible range of treatment options. As part of the Mayo Clinic Cancer Center, the Women's Cancer Program is poised to offer innovative new therapies available through clinical trials. The Women's Cancer Program also provides psychosocial support classes, a resource center, and educational programs for patients and their families.

Publications

See a list of publications by Mayo Clinic doctors on nonmelanoma skin cancer on PubMed, a service of the National Library of Medicine.